Physician Self Disclosure of IUC Use
- Conditions
- Contraception
- Interventions
- Behavioral: Usual contraceptive counselingBehavioral: Physician self-disclosure of personal IUC use
- Registration Number
- NCT01994356
- Lead Sponsor
- University of Michigan
- Brief Summary
As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.
- Detailed Description
We performed a prospective randomized block design pilot trail of usual contraceptive counseling versus usual counseling plus physician self-disclosure of personal intrauterine contraceptive use.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 132
- reproductive age
- currently sexually active
- scheduled for benign gynecology visit, annual exam, or family planning visit
- seeking pregnancy within 1 year
- currently using IUC
- prior sterilization procedure
- currently pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual contraceptive counseling Usual contraceptive counseling subjects received usual contraceptive counseling Physician self-disclosure of IUC use Physician self-disclosure of personal IUC use subjects received usual contraceptive counseling plus intervention which was Physician self-disclosure of personal IUC use during the counseling
- Primary Outcome Measures
Name Time Method Intrauterine contraceptive use immediately following clinical encounter and at 2 months All subjects were surveyed to determine use of intrauterine contraceptive immediately after their clinical visit where contraceptive counseling was received and at 2 months after their clinical encounter to assess intrauterine contraceptive use.
- Secondary Outcome Measures
Name Time Method Satisfaction with clinical encounter immediately following clinical encounter and at 2 months All subjects were surveyed to determine their with satisfaction with their overall clinical encounter immediately following their clinical encounter at at 2 months. Satisfaction was measured using a 5 point scale.
Trial Locations
- Locations (1)
University of Michigan Medical Center
🇺🇸Ann Arbor, Michigan, United States